We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$48.1B
AUM Growth
-$8.01B
(-14%)
Cap. Flow
-$10.9B
Cap. Flow
% of AUM
-22.65%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
6,176
New
664
Increased
1,651
Reduced
2,355
Closed
991
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$96M |
| 2 |
American Express
AXP
|
+$52.9M |
| 3 |
Amphenol
APH
|
+$51.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$48.2M |
| 5 |
SiriusXM
SIRI
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$92.9M |
| 2 |
Tesla
TSLA
|
+$88.9M |
| 3 |
Microsoft
MSFT
|
+$71.7M |
| 4 |
Amazon
AMZN
|
+$68.5M |
| 5 |
AutoZone
AZO
|
+$51.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.31% |
| 2 | Consumer Discretionary | 2.73% |
| 3 | Healthcare | 2.58% |
| 4 | Financials | 2.05% |
| 5 | Industrials | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
Iovance Biotherapeutics
IOVA
$2.09B
| $128K | ﹤0.01% |
13,665
-3,665
| -21% | -$34.7K |
|
4202
Agilent Technologies
A
$39.2B
| $128K | ﹤0.01% |
863
+2
| +0.2% | +$274 |
|
4203
PUT
SLM Corp
SLM
$4.86B
| $128K | ﹤0.01% |
5,600
-9,200
| -62% | -$198K |
|
4204
CALL
Cellebrite
CLBT
$3.63B
| $128K | ﹤0.01% |
+7,600
| New | +$113K |
|
4205
Shattuck Labs
STTK
$687M
| $128K | ﹤0.01% |
36,560
+6,727
| +23% | +$25.1K |
|
4206
CALL
Silicon Laboratories
SLAB
$7.15B
| $127K | ﹤0.01% |
1,100
-6,700
| -86% | -$748K |
|
4207
CALL
Vishay Intertechnology
VSH
$5.18B
| $127K | ﹤0.01% |
6,700
-10,500
| -61% | -$219K |
|
|
OPRA
4208
PUT
Opera Ltd
OPRA
$1.67B
| $127K | ﹤0.01% |
+8,200
| New | +$110K |
|
4209
Forafric Global PLC Warrants
AFRIW
$10.3M
| $126K | ﹤0.01% |
94,612
| – | – |
|
4210
Worthington Enterprises
WOR
$2.74B
| $126K | ﹤0.01% |
3,040
-74
| -2% | -$3.37K |
|
4211
Protolabs
PRLB
$1.79B
| $126K | ﹤0.01% |
+4,290
| New | +$131K |
|
4212
PUT
NovoCure
NVCR
$1.77B
| $125K | ﹤0.01% |
8,000
+900
| +13% | +$16.3K |
|
|
NVMI
4213
CALL
Nova
NVMI
$12.5B
| $125K | ﹤0.01% |
600
-7,800
| -93% | -$1.66M |
|
|
KLG
4214
CALL
DELISTED
WK Kellogg Co
KLG
| $125K | ﹤0.01% |
7,300
-14,500
| -67% | -$249K |
|
4215
PUT
dLocal
DLO
$4.41B
| $125K | ﹤0.01% |
15,600
-8,100
| -34% | -$65.6K |
|
4216
Comcast
CMCSA
$84B
| $125K | ﹤0.01% |
2,983
-386,385
| -99% | -$15.3M |
|
4217
Guardant Health
GH
$20.2B
| $125K | ﹤0.01% |
5,429
-25,895
| -83% | -$733K |
|
4218
iRhythm Holdings
IRTC
$3.91B
| $124K | ﹤0.01% |
1,676
-299
| -15% | -$23.8K |
|
|
EOSEW
4219
DELISTED
Eos Energy Enterprises Warrant
EOSEW
| $124K | ﹤0.01% |
635,840
| – | – |
|
4220
PUT
Barclays
BCS
$93.4B
| $124K | ﹤0.01% |
10,200
| – | – |
|
4221
Medifast
MED
$110M
| $124K | ﹤0.01% |
6,457
-5,017
| -44% | -$96.7K |
|
4222
Diana Shipping
DSX
$286M
| $124K | ﹤0.01% |
48,067
+17,067
| +55% | +$43.8K |
|
4223
P3 Health Partners Inc Warrant
PIIIW
$133K
| $123K | ﹤0.01% |
3,087,334
| – | – |
|
|
SRG
4224
CALL
Seritage Growth Properties
SRG
$137M
| $123K | ﹤0.01% |
26,400
| – | – |
|
4225
TG Therapeutics
TGTX
$8.19B
| $123K | ﹤0.01% |
+5,246
| New | +$115K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Walleye Capital held 6,176 positions worth $48.1B, down 14% from $56.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Walleye Capital withdrew a net $10.9B in Q3 2024, closing 991 positions and reducing 2,355 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $92.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Walleye Capital opened a new position in Cedar Fair worth $35.4M.
- Walleye Capital's largest Q3 2024 buy was Cedar Fair: 877,543 shares worth $35.4M.
- Walleye Capital added most to Invesco QQQ Trust in Q3 2024, an estimated $96M increase.
- Walleye Capital's biggest Q3 2024 reduction was Tesla, cutting an estimated $88.9M.
- Walleye Capital fully exited iShares 20+ Year Treasury Bond ETF in Q3 2024, selling an estimated $92.9M.
- Walleye Capital's ten largest holdings make up 29% of its $48.1B portfolio in Q3 2024.
- Walleye Capital opened 664 new positions and closed 991 in Q3 2024.
- Walleye Capital's portfolio value fell 14% quarter-over-quarter to $48.1B.
Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.